Viatris Targets Gilead’s Odefsey HIV Blockbuster In Europe With CHMP Recommendation

US-Based Firm Also Receives Positive Opinion For Generic To Boehringer Ingelheim’s Ofev

(Shutterstock)

More from Generics

More from Policy & Regulation